TransDigm (TDG) director granted 518 options at $1,291.97
TransDigm Group (TDG) filed a Form 4 for director Jane Cronin reporting a grant of stock options on 11/04/2025.
Rhea-AI Filing Summary
TransDigm Group (TDG) filed a Form 4 for director Jane Cronin reporting a grant of stock options on 11/04/2025. The award covers 518 options with an exercise price of $1,291.97 per share.
The options vest 20% per year over five years beginning September 30, 2026, subject to the achievement of annual operating performance targets, and expire on 11/04/2035. Following this transaction, 518 derivative securities were beneficially owned, held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 518 shares
Grant/Award
1 txn
Insider
CRONIN JANE M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 518 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 518 contracts (Direct)
Footnotes (1)
- F1. These options are exercisable at 20% per year over five years beginning September 30, 2026 subject to the achievement of annual operating performance targets in each year.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did TransDigm (TDG) disclose in this Form 4?
A director, Jane Cronin, received 518 stock options at an exercise price of $1,291.97 per share on 11/04/2025.
What is the vesting schedule for the TDG options?
They vest 20% per year over five years beginning September 30, 2026, subject to annual operating performance targets.
When do these TransDigm options expire?
The options expire on 11/04/2035.
How many derivative securities were owned after the transaction?
518 derivative securities were beneficially owned following the reported transaction.
What is the ownership form of the reported options?
The ownership form is Direct (D).
Who is the reporting person in this filing?
Jane Cronin, as indicated by the signature by attorney-in-fact.
AI-generated analysis. How Rhea-AI works. Not financial advice.